Aim To describe a decade long telemedicine screening for diabetic retinopathy (DR) in the metropolitan area of Padova (North-East Italy) and to report about prevalence/incidence of DR and maculopathy, rate of progression to STDR and optimal screening interval in patients with no DR at first examination. Methods Observational, longitudinal, cohort study; 9347 patients with Type 1 and Type 2 diabetes mellitus (DM) underwent 17,344 fundus exams (three-45° color photos per eye) in two diabetes clinics and were graded in the Reading Centre, by certified personnel. The incidence of STDR, progression of maculopathy and risk factors were evaluated by log Rank test (Kaplan–Meier method). A receiver operating curve was used to determine the optimal screening interval in patients who at the first examination had no DR. Results The overall prevalence of DR was 27.6%:12.5% mild non proliferative (NPDR), 11.3% moderate NPDR, 2.9% severe NPDR and 0.9% proliferative (PDR). The overall prevalence of maculopathy was 5.7%: 2.8% mild, 2.2% moderate, and 0.7% severe maculopathy. The 10-year incidence of STDR was: 0.6% in no DR, 5.5% in mild NPDR and 21.1% in moderate NPDR at first examination. The 10-year incidence of maculopathy was: 2.1% mild, 1.7% moderate and 0.2% severe. The incidence of STDR in patients with type 1 and type 2 DM and duration > 10 years was 8.21% and 8.15%;in type 1 DM with duration < 10 years was 5.5% and in type 2 DM and duration < 10 years was 1.91%.In patients with no DR at first screening, the best (sensitivity-specificity) follow-up interval is 2.5 years. Conclusions Screening every 2.5-year in patients without DR at the first examination seems to be adequate. Duration of disease is a relevant risk factor for progression to STDR, however patients with type 1 DM and duration < 10 years have greater incidence of STDR than patients with type 2 DM and similar disease duration. Epidemiologic data from this decade-long screening program in the North East of Italy may serve for implementing a national screening program.

A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy / S. Vujosevic, P. Pucci, M. Casciano, A. Daniele, S. Bini, M. Berton, F. Cavarzeran, A. Avogaro, A. Lapolla, E. Midena. - In: JOURNAL OF DIABETES AND ITS COMPLICATIONS. - ISSN 1056-8727. - 31:8(2017), pp. 1348-1353. [10.1016/j.jdiacomp.2017.04.010]

A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy

S. Vujosevic
Primo
;
2017

Abstract

Aim To describe a decade long telemedicine screening for diabetic retinopathy (DR) in the metropolitan area of Padova (North-East Italy) and to report about prevalence/incidence of DR and maculopathy, rate of progression to STDR and optimal screening interval in patients with no DR at first examination. Methods Observational, longitudinal, cohort study; 9347 patients with Type 1 and Type 2 diabetes mellitus (DM) underwent 17,344 fundus exams (three-45° color photos per eye) in two diabetes clinics and were graded in the Reading Centre, by certified personnel. The incidence of STDR, progression of maculopathy and risk factors were evaluated by log Rank test (Kaplan–Meier method). A receiver operating curve was used to determine the optimal screening interval in patients who at the first examination had no DR. Results The overall prevalence of DR was 27.6%:12.5% mild non proliferative (NPDR), 11.3% moderate NPDR, 2.9% severe NPDR and 0.9% proliferative (PDR). The overall prevalence of maculopathy was 5.7%: 2.8% mild, 2.2% moderate, and 0.7% severe maculopathy. The 10-year incidence of STDR was: 0.6% in no DR, 5.5% in mild NPDR and 21.1% in moderate NPDR at first examination. The 10-year incidence of maculopathy was: 2.1% mild, 1.7% moderate and 0.2% severe. The incidence of STDR in patients with type 1 and type 2 DM and duration > 10 years was 8.21% and 8.15%;in type 1 DM with duration < 10 years was 5.5% and in type 2 DM and duration < 10 years was 1.91%.In patients with no DR at first screening, the best (sensitivity-specificity) follow-up interval is 2.5 years. Conclusions Screening every 2.5-year in patients without DR at the first examination seems to be adequate. Duration of disease is a relevant risk factor for progression to STDR, however patients with type 1 DM and duration < 10 years have greater incidence of STDR than patients with type 2 DM and similar disease duration. Epidemiologic data from this decade-long screening program in the North East of Italy may serve for implementing a national screening program.
Diabetic maculopathy; Diabetic retinopathy screening; Epidemiology; Sight threatening diabetic retinopathy; Telemedicine
Settore MED/30 - Malattie Apparato Visivo
Settore MED/13 - Endocrinologia
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
JDC-2017.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 380.65 kB
Formato Adobe PDF
380.65 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/881252
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 31
social impact